Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Bronchoretard vs Theo-Dur
NCT02184247Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Apr 1998
- Primary completion
- May 1998
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of Bronchoretard in asthma and chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Maximum concentration, Area under the plasma concentration versus time curve and 2 more. Started Apr 1998; status: completed.
02
Drugs
Bronchoretard
03
Conditions
asthmachronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02184247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02184247.